INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Clinical trials for INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) explained in plain language.
Never miss a new study
Get alerted when new INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) trials appear
Sign up with your email to follow new studies for INTRAHEPATIC CHOLANGIOCARCINOMA (ICC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple-drug attack shows promise for hard-to-treat liver cancer
Disease control Recruiting nowThis study tests a combination of two drugs (apatinib and adebrelimab) plus chemotherapy (GEMOX) as a first treatment for people with advanced intrahepatic cholangiocarcinoma, a type of bile duct cancer that cannot be removed by surgery. The goal is to see if this mix shrinks tum…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated May 17, 2026 01:35 UTC
-
New hope for liver cancers: targeted chemo plus immune booster shows promise
Disease control Recruiting nowThis study tests whether adding an immune-boosting drug (PDS01ADC) to standard liver-directed chemotherapy can help people with certain cancers that have spread to the liver. About 70 adults with colorectal cancer, bile duct cancer, or adrenal cancer that is mainly in the liver w…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New triple therapy shows promise for hard-to-treat bile duct cancer
Disease control Recruiting nowThis study tests a new first-line treatment for people with advanced bile duct cancer that cannot be removed by surgery. The treatment combines chemotherapy delivered directly to the liver (HAIC) with two drugs: durvalumab (an immunotherapy) and lenvatinib (a targeted therapy). T…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Simple blood test could catch deadly bile duct cancers early
Diagnosis Recruiting nowThis study is testing a blood test that looks for DNA changes from cancer cells to detect biliary tract cancers (cancers of the bile ducts and gallbladder) earlier. These cancers are often found late, making them hard to treat. The test aims to improve diagnosis and help doctors …
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Sponsor: Yingbin Liu, MD, PhD, FACS • Aim: Diagnosis
Last updated May 17, 2026 01:36 UTC
-
New scan could spot bile duct cancers more accurately
Diagnosis Recruiting nowThis study looks at whether a new type of PET scan (FAPI PET) can find and stage biliary tract cancers (gallbladder and bile duct cancers) better than the standard FDG PET scan. About 60 adults with suspected or confirmed cancer will get both scans to compare accuracy. The goal i…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Sponsor: Tata Memorial Centre • Aim: Diagnosis
Last updated May 13, 2026 16:01 UTC
-
New PET tracer could sharpen cancer detection for Hard-to-Image tumors
Diagnosis Recruiting nowThis study is testing a new radioactive tracer called 89Zr-TLX250 to see if it can better detect liver cancers (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) and pancreatic neuroendocrine tumors on PET-CT scans. About 60 adults with these cancers will receive the …
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Phase: NA • Sponsor: Nantes University Hospital • Aim: Diagnosis
Last updated May 12, 2026 13:41 UTC
-
New scout dose method could make liver cancer treatment safer for lungs
Knowledge-focused Recruiting nowThis study involves 30 adults with liver tumors who are scheduled for radioembolization, a treatment that delivers radiation directly to the tumor via tiny beads. Doctors currently use a test with a different particle (MAA) to see if the treatment might harm the lungs, but this t…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Phase: NA • Sponsor: Seoul National University Hospital • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC